<i>From the Bench: </i>Alfama shows carbon monoxide can be therapeutic, if they can deliver it

Tue, 09/28/2010 - 8:34pm
Mass High Tech: The Journal of New England Technology

Forget what Mom and Dad said about carbon monoxide being bad. OK, don’t forget that, but to give what scientists call CO a fair shake, you have to consider that there’s a good side to CO.

That’s what Alfama Inc. is focused on.

The life sciences company based in Cambridge and Portugal sees carbon monoxide as a therapy for a significant number of medical conditions, including liver failure, rheumatoid arthritis, heart attack and gastric ulcers. The trick is in delivering CO to the disease site without causing the problems that most people associate with the gas. So, Alfama is working on carbon monoxide releasing molecules (CO-RMs) that would deliver CO to diseased tissue without harming healthy tissue.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.